[The French preliminary experience of the use of a seed-projector for exclusive iodine 125 prostate brachytherapy: feasibility and acute toxicity]

Cancer Radiother. 2006 Dec;10(8):559-64. doi: 10.1016/j.canrad.2006.07.008. Epub 2006 Sep 7.
[Article in French]

Abstract

Purpose: To analyse a new technique for prostate brachytherapy with permanent Iodine implants characterized by the use of a seed projector after a 3D dosimetric peroperative treatment planning (FIRST technique).

Patients and method: 395 patients have been treated in France with this technique in six radiotherapy centres between November 2002 and December 2005 for a localized prostate cancer.

Results: Thirteen patients (3.3%) developped a urinary retention, and respectively 7.8 and 26.5% an acute RTOG grade 3 and 2 toxicity. The 6-weeks IPSS score was equal or lower to 15 in 73% with a 11 median IPSS value. A failure of the loading with the seed-projector, leading to a manual loading of the seeds, occurred in 9 patients (2.3%) in two centres, directly related to the loading procedure with the seed-projector in 5 cases. The median duration of the procedure was reduced by 30 minutes for the patients treated in 2005.

Conclusions: This multicenter study establishes the feasibility of the routine use of a seed projector for permanent iodine 125 prostate implants with an initial tolerance similar to the best results published for other implants techniques.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract
  • Multicenter Study

MeSH terms

  • Brachytherapy / adverse effects*
  • Brachytherapy / methods*
  • Feasibility Studies
  • Follow-Up Studies
  • France
  • Humans
  • Imaging, Three-Dimensional
  • Iodine Radioisotopes / administration & dosage*
  • Male
  • Neoplasm Staging
  • Prostate / pathology
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*
  • Radiotherapy Planning, Computer-Assisted
  • Time Factors
  • Urinary Retention / etiology

Substances

  • Iodine Radioisotopes
  • Prostate-Specific Antigen